Bleaker outlook for Russian palliative-care patients
Economic crunch puts treatment and pain drugs out of reach for many patients, who have also become collateral damage in government's intensifying war against drug trafficking
Nakhabino, Russia
FOR the five years that doctors have battled the cancerous tumour pressing on her son's spine, Elena Knyazeva has faced an ever-harder struggle to help him weather the pain.
Diagnosed with virulent neuroblastoma at four months, Artyom - now five years old - has had multiple surgeries and rounds of chemotherapy. As a Russian citizen whose family has state-mandated health insurance, he is, in theory, entitled to all the benefits of the Russian public healthcare system.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue